Case report: MELAS and T3271C mitochondrial mutation in an adult woman

IntroductionPatients with mitochondrial disorders always show neurological deficits. However, the diversity of clinical manifestations, genetic heterogeneity and threshold effect caused by maternal heredity make its diagnosis very challenging.Case presentationA 30-year-old female presented to our ne...

Full description

Bibliographic Details
Main Authors: Dong-hua Chen, Wei Li, Hai-shan Jiang, Chao Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1179992/full
_version_ 1797771189963194368
author Dong-hua Chen
Wei Li
Hai-shan Jiang
Chao Yuan
author_facet Dong-hua Chen
Wei Li
Hai-shan Jiang
Chao Yuan
author_sort Dong-hua Chen
collection DOAJ
description IntroductionPatients with mitochondrial disorders always show neurological deficits. However, the diversity of clinical manifestations, genetic heterogeneity and threshold effect caused by maternal heredity make its diagnosis very challenging.Case presentationA 30-year-old female presented to our neurology department with a recurrence of symmetrical weakness proximally in the lower extremities. Seven years ago, the patient had a sudden onset of persistent weakness in bilateral proximal lower extremities, along with elevated creatinine kinase (CK) and CK-MB. Given the diagnosis of Guillain-Barre syndrome, she was treated with high-dose glucocorticoid (GC) therapy at the local hospital and recovered. After admission to our hospital, laboratory analysis revealed elevated CK and alpha-hydroxybutyrate dehydrogenase in serum. Electrocardiography showed sinus tachycardia and left high ventricular voltage. Electromyography (EMG) and evoked potential (EP) suggested peripheral neurogenic damage of the upper and lower extremities with myogenic wear. Chronic inflammatory demyelinating polyneuropathy (CIDP) was initially considered, but neurological symptoms were not significantly improved with glucocorticoid shock therapy. An elevated level of lactate was found. The short-tau inversion recovery (STIR) axial magnetic resonance image (MRI) revealed mild hyperintensities, indicating muscle edema. Meanwhile, muscle biopsies suggested pathological changes in mitochondrial disorders (MIDs) and neuronal damage. Further mitochondrial genome analysis revealed a heteroplasmic m3271 T>C mutation in the mitochondrial tRNA-Leu gene (UUR). Collectively, the patient was finally diagnosed with mitochondrial disorder and apparently improved after the corresponding treatment to regulate energy metabolism.ConclusionsTo our knowledge, it's the first report about MELAS with 3271 mutation that have only shown peripheral nerve motion impairment. Proximal weakness is also common in CIDP. In the context of this patient's experience, mitochondrial genome analysis provides an auxiliary criterion for differential diagnosis between MIDs and CIDP. In the meantime, we discussed the clinical effect of GCs on MIDs.
first_indexed 2024-03-12T21:32:54Z
format Article
id doaj.art-c91d8458c6e5411ea3a28460ac4f89eb
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-03-12T21:32:54Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-c91d8458c6e5411ea3a28460ac4f89eb2023-07-27T15:32:16ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-07-011410.3389/fneur.2023.11799921179992Case report: MELAS and T3271C mitochondrial mutation in an adult womanDong-hua ChenWei LiHai-shan JiangChao YuanIntroductionPatients with mitochondrial disorders always show neurological deficits. However, the diversity of clinical manifestations, genetic heterogeneity and threshold effect caused by maternal heredity make its diagnosis very challenging.Case presentationA 30-year-old female presented to our neurology department with a recurrence of symmetrical weakness proximally in the lower extremities. Seven years ago, the patient had a sudden onset of persistent weakness in bilateral proximal lower extremities, along with elevated creatinine kinase (CK) and CK-MB. Given the diagnosis of Guillain-Barre syndrome, she was treated with high-dose glucocorticoid (GC) therapy at the local hospital and recovered. After admission to our hospital, laboratory analysis revealed elevated CK and alpha-hydroxybutyrate dehydrogenase in serum. Electrocardiography showed sinus tachycardia and left high ventricular voltage. Electromyography (EMG) and evoked potential (EP) suggested peripheral neurogenic damage of the upper and lower extremities with myogenic wear. Chronic inflammatory demyelinating polyneuropathy (CIDP) was initially considered, but neurological symptoms were not significantly improved with glucocorticoid shock therapy. An elevated level of lactate was found. The short-tau inversion recovery (STIR) axial magnetic resonance image (MRI) revealed mild hyperintensities, indicating muscle edema. Meanwhile, muscle biopsies suggested pathological changes in mitochondrial disorders (MIDs) and neuronal damage. Further mitochondrial genome analysis revealed a heteroplasmic m3271 T>C mutation in the mitochondrial tRNA-Leu gene (UUR). Collectively, the patient was finally diagnosed with mitochondrial disorder and apparently improved after the corresponding treatment to regulate energy metabolism.ConclusionsTo our knowledge, it's the first report about MELAS with 3271 mutation that have only shown peripheral nerve motion impairment. Proximal weakness is also common in CIDP. In the context of this patient's experience, mitochondrial genome analysis provides an auxiliary criterion for differential diagnosis between MIDs and CIDP. In the meantime, we discussed the clinical effect of GCs on MIDs.https://www.frontiersin.org/articles/10.3389/fneur.2023.1179992/fullMELAST3271C mutationperipheral nerve dysfunctionglucocorticoid therapycase report
spellingShingle Dong-hua Chen
Wei Li
Hai-shan Jiang
Chao Yuan
Case report: MELAS and T3271C mitochondrial mutation in an adult woman
Frontiers in Neurology
MELAS
T3271C mutation
peripheral nerve dysfunction
glucocorticoid therapy
case report
title Case report: MELAS and T3271C mitochondrial mutation in an adult woman
title_full Case report: MELAS and T3271C mitochondrial mutation in an adult woman
title_fullStr Case report: MELAS and T3271C mitochondrial mutation in an adult woman
title_full_unstemmed Case report: MELAS and T3271C mitochondrial mutation in an adult woman
title_short Case report: MELAS and T3271C mitochondrial mutation in an adult woman
title_sort case report melas and t3271c mitochondrial mutation in an adult woman
topic MELAS
T3271C mutation
peripheral nerve dysfunction
glucocorticoid therapy
case report
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1179992/full
work_keys_str_mv AT donghuachen casereportmelasandt3271cmitochondrialmutationinanadultwoman
AT weili casereportmelasandt3271cmitochondrialmutationinanadultwoman
AT haishanjiang casereportmelasandt3271cmitochondrialmutationinanadultwoman
AT chaoyuan casereportmelasandt3271cmitochondrialmutationinanadultwoman